The stock of Medical Properties Trust Inc (NYSE: MPW) has decreased by -2.35 when compared to last closing price of 4.46.Despite this, the company has seen a loss of -1.91% in its stock price over the last five trading days. seekingalpha.com reported 2025-06-28 that “One Big Beautiful Bill” inches closer to becoming law. It will have an impact on the broader economy, and especially certain specific sectors. Some dividend stocks could be in serious trouble, while others could gain. I share my take as a dividend investor.
Is It Worth Investing in Medical Properties Trust Inc (NYSE: MPW) Right Now?
Additionally, the 36-month beta value for MPW is 1.35. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 1 rating it as “sell.”
The public float for MPW is 493.28M and currently, short sellers hold a 35.34% ratio of that float. The average trading volume of MPW on June 30, 2025 was 9.30M shares.
MPW’s Market Performance
MPW stock saw a decrease of -1.91% in the past week, with a monthly decline of -5.53% and a quarterly a decrease of -27.90%. The volatility ratio for the week is 2.49%, and the volatility levels for the last 30 days are 2.94% for Medical Properties Trust Inc (MPW). The simple moving average for the past 20 days is -2.60% for MPW’s stock, with a -11.03% simple moving average for the past 200 days.
Analysts’ Opinion of MPW
Many brokerage firms have already submitted their reports for MPW stocks, with Exane BNP Paribas repeating the rating for MPW by listing it as a “Outperform.” The predicted price for MPW in the upcoming period, according to Exane BNP Paribas is $9 based on the research report published on March 12, 2025 of the current year 2025.
Colliers Securities, on the other hand, stated in their research note that they expect to see MPW reach a price target of $6.50. The rating they have provided for MPW stocks is “Buy” according to the report published on September 13th, 2024.
Exane BNP Paribas gave a rating of “Neutral” to MPW, setting the target price at $4 in the report published on July 02nd of the previous year.
MPW Trading at -9.81% from the 50-Day Moving Average
After a stumble in the market that brought MPW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.51% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MPW starting from Stewart Michael G, who sale 29,000 shares at the price of $5.20 back on May 05 ’25. After this action, Stewart Michael G now owns 216,100 shares of Medical Properties Trust Inc, valued at $150,800 using the latest closing price.
Stock Fundamentals for MPW
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.64 for the gross margin
The net margin for Medical Properties Trust Inc stands at -1.72. The total capital return value is set at 0.0. Equity return is now at value -28.86, with -10.29 for asset returns.
Based on Medical Properties Trust Inc (MPW), the company’s capital structure generated 0.67 points at debt to capital in total, while cash flow to debt ratio is standing at 0.02. The debt to equity ratio resting at 2.02. The interest coverage ratio of the stock is 0.1.
Currently, EBITDA for the company is 840.6 million with net debt to EBITDA at -12.92. When we switch over and look at the enterprise to sales, we see a ratio of 12.19. The receivables turnover for the company is 1.21for trailing twelve months and the total asset turnover is 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.28.
Conclusion
In conclusion, Medical Properties Trust Inc (MPW) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
